Josefin Holmgren, Emma Englund, Annelie Carlsson, Linda Litwin, Constance G Weismann, Michal Odermarsky, Petru Liuba
{"title":"Young Healthy Individuals With a First-Degree Relative With Type 1 Diabetes Displayed Adverse Lipid Changes.","authors":"Josefin Holmgren, Emma Englund, Annelie Carlsson, Linda Litwin, Constance G Weismann, Michal Odermarsky, Petru Liuba","doi":"10.1111/apa.70002","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>Timeline of atherosclerosis in children with type 1 diabetes is unknown. We aimed to investigate if familial risk of type 1 diabetes is associated with pro-atherosclerotic changes.</p><p><strong>Methods: </strong>Young first-degree relatives to patients with paediatric type 1 diabetes and sex and age matching controls were enrolled at Skåne University Hospital, Sweden between 2006 and 2015. Conventional lipids, human leukocyte antigen DQ2/8, inflammatory biomarkers, and history of respiratory infections were determined.</p><p><strong>Results: </strong>A total of 117 first-degree relatives and 43 controls were recruited (50% boys) at median of 13.4 years of age (IQR 8.0). Relatives had lower BMI Z-score (p = 0.03) and frequency of respiratory infections (p = 0.03) compared to controls, but higher low-density lipoprotein (LDL, p = 0.04) and total cholesterol (p = 0.01). In multivariable regression models adjusted for confounders LDL was 0.35 mmol/L higher (95% CI 0.10-0.61) and total cholesterol was 0.46 mmol/L higher (95% CI 0.15-0.77) in relatives. Relatives with ≥ 4 respiratory infections/year had higher LDL than controls with < 4 infections/year (p = 0.035). Human leukocyte antigen DQ2/8 frequency and inflammatory biomarkers did not differ between groups.</p><p><strong>Conclusion: </strong>Healthy young relatives to patients with type 1 diabetes display adverse lipid changes, probably related to their genetic susceptibility to this disease and recent respiratory infections.</p>","PeriodicalId":55562,"journal":{"name":"Acta Paediatrica","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Paediatrica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/apa.70002","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: Timeline of atherosclerosis in children with type 1 diabetes is unknown. We aimed to investigate if familial risk of type 1 diabetes is associated with pro-atherosclerotic changes.
Methods: Young first-degree relatives to patients with paediatric type 1 diabetes and sex and age matching controls were enrolled at Skåne University Hospital, Sweden between 2006 and 2015. Conventional lipids, human leukocyte antigen DQ2/8, inflammatory biomarkers, and history of respiratory infections were determined.
Results: A total of 117 first-degree relatives and 43 controls were recruited (50% boys) at median of 13.4 years of age (IQR 8.0). Relatives had lower BMI Z-score (p = 0.03) and frequency of respiratory infections (p = 0.03) compared to controls, but higher low-density lipoprotein (LDL, p = 0.04) and total cholesterol (p = 0.01). In multivariable regression models adjusted for confounders LDL was 0.35 mmol/L higher (95% CI 0.10-0.61) and total cholesterol was 0.46 mmol/L higher (95% CI 0.15-0.77) in relatives. Relatives with ≥ 4 respiratory infections/year had higher LDL than controls with < 4 infections/year (p = 0.035). Human leukocyte antigen DQ2/8 frequency and inflammatory biomarkers did not differ between groups.
Conclusion: Healthy young relatives to patients with type 1 diabetes display adverse lipid changes, probably related to their genetic susceptibility to this disease and recent respiratory infections.
期刊介绍:
Acta Paediatrica is a peer-reviewed monthly journal at the forefront of international pediatric research. It covers both clinical and experimental research in all areas of pediatrics including:
neonatal medicine
developmental medicine
adolescent medicine
child health and environment
psychosomatic pediatrics
child health in developing countries